Literature DB >> 21731843

Recurrent catatonia treated with lithium and carbamazepine: a series of 2 cases.

Susanta K Padhy1, Bn Subodh, Rahul Bharadwaj, K Arun Kumar, Suresh Kumar, Mk Srivastava.   

Abstract

Entities:  

Year:  2011        PMID： 21731843      PMCID： PMC3121201          DOI： 10.4088/PCC.10l00992

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  15 in total

1.  Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers.

Authors:  H K Manji; G J Moore; G Chen
Journal:  Br J Psychiatry       Date:  2001-06       Impact factor: 9.319

2.  [Contributions to the somatology of periodic catatonia. Report X. Pathogenetic considerations].

Authors:  R GJESSING
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1960

3.  Risperidone treatment of periodic catatonia.

Authors:  Harpreet S Duggal; Gaurav Gandotra
Journal:  Can J Psychiatry       Date:  2005-03       Impact factor: 4.356

4.  Identification of a lithium interaction site in the gamma-aminobutyric acid (GABA) transporter GAT-1.

Authors:  Yonggang Zhou; Elia Zomot; Baruch I Kanner
Journal:  J Biol Chem       Date:  2006-06-06       Impact factor: 5.157

5.  Treatment of periodic catatonia with olanzapine: a case report.

Authors:  Carlos Simon Guzman; Viviane Hyun Mi Myung; Yuan Pang Wang
Journal:  Braz J Psychiatry       Date:  2007-12       Impact factor: 2.697

6.  Lithium in the treatment of periodic catatonia: a case report.

Authors:  D Wald; J Lerner
Journal:  Am J Psychiatry       Date:  1978-06       Impact factor: 18.112

Review 7.  Catatonia in psychiatric classification: a home of its own.

Authors:  Michael Alan Taylor; Max Fink
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

8.  Lithium treatment of a patient with periodic catatonia.

Authors:  H Petursson
Journal:  Acta Psychiatr Scand       Date:  1976-10       Impact factor: 6.392

9.  Periodic catatonia: a schizophrenic subtype with major gene effect and anticipation.

Authors:  G Stöber; E Franzek; K P Lesch; H Beckmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

Review 10.  Is neuroleptic malignant syndrome a neurogenic form of malignant hyperthermia?

Authors:  Ronald J Gurrera
Journal:  Clin Neuropharmacol       Date:  2002 Jul-Aug       Impact factor: 1.592
View more
  5 in total

Review 1.  A clinical review of the treatment of catatonia.

Authors:  Pascal Sienaert; Dirk M Dhossche; Davy Vancampfort; Marc De Hert; Gábor Gazdag
Journal:  Front Psychiatry       Date:  2014-12-09       Impact factor: 4.157

2.  Factors associated with the risk of relapse in schizophrenic patients after a response to electroconvulsive therapy: a retrospective study.

Authors:  Chiyo Shibasaki; Minoru Takebayashi; Yasutaka Fujita; Shigeto Yamawaki
Journal:  Neuropsychiatr Dis Treat       Date:  2015-01-05       Impact factor: 2.570

3.  Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders.

Authors:  Wataru Omori; Kei Itagaki; Naoto Kajitani; Hiromi Abe; Mami Okada-Tsuchioka; Yasumasa Okamoto; Minoru Takebayashi
Journal:  Psychiatry Clin Neurosci       Date:  2019-06-01       Impact factor: 5.188

4.  Catatonia associated with late-life psychosis successfully treated with lithium: a case report.

Authors:  Hiroko Sugawara; Junpei Takamatsu; Mamoru Hashimoto; Manabu Ikeda
Journal:  Ann Gen Psychiatry       Date:  2021-02-18       Impact factor: 3.455

Review 5.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.